Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Federal advisory committees could assist FDA supplement claim review, CSPI suggests.

This article was originally published in The Tan Sheet

Executive Summary

FEDERAL ADVISORY CMTES. COULD AID FDA SUPPLEMENT CLAIM REVIEW, CSPI suggested at the eighth meeting of the President's Commission on Dietary Supplement Labels, held March 4 in Baltimore, Md. To expedite the claim review process, Center for Science in the Public Interest Legal Affairs Director Bruce Silverglade recommended the use of federal advisory committees to assist FDA in reviewing claims made for dietary supplements.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086774

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel